Moreover, a genetic algorithm analysis revealed that only two markers, the percentage of HLA-DR+ CD4+ T cells and the number of CD57+CD28- CD4+ T cells were able to predict ANI and MND with 73% accuracy, 76% sensitivity, and 70% specificity. The gene discussed is B3GAT1; the disease is asymptomatic neurocognitive impairment.